消化器腫瘍委員会
| 委員長 | 神宮 啓一 | 東北大学大学院医学系研究科 | |
|---|---|---|---|
| 委員 | 礒橋 文明 | 奈良県立医科大学 | |
| 板坂 聡 | 倉敷中央病院 | ||
| 理事 | 伊藤 芳紀 | 昭和大学医学部 | |
| 岡本 雅彦 | 群馬大学 | ||
| 理事 | 小川 和彦 | 大阪大学大学院医学系研究科 | |
| 理事 | 木村 智樹 | 高知大学医学部 | |
| 権丈 雅浩 | 広島県立広島がん高精度放射線治療センター | ||
| 佐貫直子 | 市立四日市病院 | ||
| 髙橋 健夫 | 埼玉医科大学総合医療センター | ||
| 武田 篤也 | 大船中央病院 | ||
| 玉本 哲郎 | 奈良県立医科大学附属病院 | ||
| 土井 啓至 | 近畿大学医学部 | ||
| 根来 慶春 | 日本赤十字社和歌山医療センター | ||
| 村上 祐司 | 広島大学病院 | ||
| 村田 和俊 | 群馬大学医学部附属病院 |
活動状況報告
- ① 結果発表
- ・頸部食道癌に対する強度変調放射線治療（IMRT：Intensity Modulated Radiation Therapy）を用いた化学放射線療法の多施設共同第II相臨床試験（JROSG12-1）（目標症例集積完了）第78回食道学会発表 2024年7月
- ・Murofushi KN, Itasaka S, Shimokawa M, Murakami Y, Yamamoto T, Nishimura Y, Kudo S, Sakamoto T, Ariga T, Ogo E, Taguchi K, Jingu K, Ogawa K. A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canal (the JROSG 10-2 trial). J Radiat Res. 2023 Jan 20;64(1):154-161.
- ・Murakami Y, Kenjo M, Ishikawa K, Sakayauchi T, Itasaka S, Negoro Y, Jingu K, Nishimura Y, Nagata Y, Ogawa K. Risk factors for severe gastrointestinal toxicity in patients receiving palliative radiotherapy for metastatic bone tumors: association with the use of molecular-targeted agents. J Radiat Res. 2020 Jul 6;61(4):629-634.
- ・Jingu K, Takahashi N, Murakami Y, Ishikawa K, Itasaka S, Takahashi T, Isohashi F, Sakayauchi T, Ogawa K; JROSG Working Subgroup of Gastrointestinal Cancers. Is Concurrent Chemotherapy With Radiotherapy for Esophageal Cancer Beneficial in Patients Aged 80 Years or Older? Anticancer Res. 2019 Aug;39(8):4279-4283.
- ・大腸癌肺転移に対する体幹部定位放射線治療成績（ASTRO 2016発表、論文受理、Jingu K, Matsuo Y, Onishi H, Yamamoto T, Aoki M, Murakami Y, Yamashita H, Kakuhara H, Nemoto K, Sakayauchi T, Okamoto M, Niibe Y, Nagata Y, Ogawa K. Dose Escalation Improves Outcome in Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer. Anticancer Res. 2017 May;37(5):2709-2713.）
- ・Nishimura Y, Jingu K, Itasaka S, Negoro Y, Murakami Y, Karasawa K, Kawaguchi G, Isohashi F, Kobayashi M, Itoh Y, Ariga T. Clinical outcomes of radiotherapy for esophageal cancer between 2004 and 2008: the second survey of the Japanese Radiation Oncology Study Group (JROSG). Int J Clin Oncol. 2016 Feb;21(1):88-94.
- ・Hayashi K, Isohashi F, Ogawa K, Oikawa H, Onishi H, Ito Y, Takemoto M, Karasawa K, Imai M, Kosaka Y, Yamazaki H, Yoshioka Y, Nemoto K, Nishimura Y; JAPANESE RADIATION ONCOLOGY STUDY GROUP (JROSG). Postoperative External Irradiation of Patients with Primary Biliary Tract Cancer: A Multicenter Retrospective Study. Anticancer Res. 2015 Nov;35(11):6231-7.
- ・Yoshioka Y, Ogawa K, Oikawa H, Onishi H, Kanesaka N, Tamamoto T, Kosugi T, Hatano K, Kobayashi M, Ito Y, Takayama M, Takemoto M, Karasawa K, Nagakura H, Imai M, Kosaka Y, Yamazaki H, Isohashi F, Nemoto K, Nishimura Y; Japanese Radiation Oncology Study Group (JROSG). Impact of intraluminal brachytherapy on survival outcome for radiation therapy for unresectable biliary tract cancer: a propensity-score matched-pair analysis. Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):822-9.
- ・Isohashi F, Ogawa K, Oikawa H, Onishi H, Uchida N, Maebayashi T, Kanesaka N, Tamamoto T, Asakura H, Kosugi T, Uno T, Ito Y, Karasawa K, Takayama M, Manabe Y, Yamazaki H, Takemoto M, Yoshioka Y, Nemoto K, Nishimura Y; Japanese Radiation Oncology study Group (JROSG). Patterns of radiotherapy practice for biliary tract cancer in Japan: results of the Japanese radiation oncology study group (JROSG) survey. Radiat Oncol. 2013 Apr 1;8:76.
- ・Nishimura Y, Koike R, Ogawa K, Sasamoto R, Murakami Y, Itoh Y, Negoro Y, Itasaka S, Sakayauchi T, Tamamoto T. Clinical practice and outcome of radiotherapy for esophageal cancer between 1999 and 2003: the Japanese Radiation Oncology Study Group (JROSG) Survey. Int J Clin Oncol. 2012 Feb;17(1):48-54
- ・Ogawa K, Shibuya H, Uchida N, Onishi H, Okuno Y, Myojin M, Kobayashi M, Ogawa Y, Kanesaka N, Shibuya K, Tokumaru S, Sasamoto R, Karasawa K, Nemoto K, Nishimura Y; JROSG WORKING SUBGROUP of GASTROINTESTINAL CANCER. Postoperative external beam radiotherapy for resected pancreatic adenocarcinoma: impact of chemotherapy on local control and survival. Anticancer Res. 2010 Jul;30(7):2959-67.
- ・Ogawa K, Karasawa K, Ito Y, Ogawa Y, Jingu K, Onishi H, Aoki S, Wada H, Kokubo M, Ogo E, Etoh H, Kazumoto T, Takayama M, Nemoto K, Nishimura Y; JROSG Working Subgroup of Gastrointestinal Cancers. Intraoperative radiotherapy for unresectable pancreatic cancer: a multi-institutional retrospective analysis of 144 patients. Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):111-8
- ・Ogawa K, Karasawa K, Ito Y, Ogawa Y, Jingu K, Onishi H, Aoki S, Wada H, Kokubo M, Etoh H, Kazumoto T, Takayama M, Negoro Y, Nemoto K, Nishimura Y; JROSG Working Subgroup of Gastrointestinal Cancers. Intraoperative radiotherapy for resected pancreatic cancer: a multi-institutional retrospective analysis of 210 patients. Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):734-42.
- ・Ogawa K, Ito Y, Karasawa K, Ogawa Y, Onishi H, Kazumoto T, Shibuya K, Shibuya H, Okuno Y, Nishino S, Ogo E, Uchida N, Karasawa K, Nemoto K, Nishimura Y; JROSG Working Subgroup of Gastrointestinal Cancers. Patterns of radiotherapy practice for pancreatic cancer in Japan: results of the Japanese Radiation Oncology Study Group (JROSG) survey. Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):743-50
- ② 研究準備中
- ・小型肝細胞癌に対する定位放射線治療症例の前向き登録データを用いた統合的解析（ドラフト提出済み）
2025年2月20日更新
Instagram
